You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

alectinib

Showing 26 - 47 of 47
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Worldwide (Alectinib, Crizotinib)

Active, not recruiting
Has Results
  • Non-Small Cell Lung Cancer
  • Phoenix, Arizona
  • +125 more
Dec 2, 2022

ALK+ Advanced NSCLC Trial in Worldwide (Brigatinib, Alectinib)

Recruiting
  • ALK+ Advanced NSCLC
  • Whittier, California
  • +113 more
Apr 1, 2022

NSCLC Trial in United States (Alectinib, Entrectinib, Vemurafenib)

Recruiting
  • Non-small Cell Lung Cancer
  • Alectinib
  • +8 more
  • Duarte, California
  • +24 more
Feb 2, 2023

Breast Cancer, Gastrointestinal Cancer, Non Small Cell Lung Cancer Trial in Italy (Erlotinib, Trastuzumab, Trastuzumab

Recruiting
  • Breast Cancer
  • +3 more
  • Ancona, Italy
  • +40 more
Jan 25, 2023

Solid Tumor, Haematological Malignancy Trial in United Kingdom (Alectinib, Atezolizumab, Entrectinib)

Recruiting
  • Solid Tumor
  • Haematological Malignancy
  • Alectinib
  • +4 more
  • Belfast, United Kingdom
  • +24 more
Jan 31, 2023

NSCLC (NSCLC) Trial in Boston (Alectinib, Bevacizumab)

Unknown status
  • Non-Small Cell Lung Cancer (NSCLC)
  • Boston, Massachusetts
  • +1 more
Nov 25, 2019

NSCLC Trial in Worldwide (Alectinib, Atezolizumab, Erlotinib)

Completed
  • Non-Small Cell Lung Cancer
  • Alectinib
  • +2 more
  • Orange, California
  • +16 more
Apr 17, 2020

NSCLC Trial in France (Alectinib)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Alectinib
  • Angers, France
  • +15 more
Feb 7, 2020

NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • Duarte, California
  • +52 more
Jan 19, 2023

Cancer, Tumors, Tumor Trial in Netherlands (Panitumumab, Olaparib, Dabrafenib)

Recruiting
  • Cancer
  • +3 more
  • Amersfoort, Utrecht, Netherlands
  • +34 more
Oct 26, 2021

Anaplastic Lymphoma Kinase-positive NSCLC Trial in China, Korea, Republic of, Thailand (Alectinib, Crizotinib)

Unknown status
Has Results
  • Anaplastic Lymphoma Kinase-positive Non-small Cell Lung Cancer
  • Beijing, China
  • +23 more
Sep 6, 2019

Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)

Recruiting
  • Advanced Unresectable or Metastatic Solid Malignancy
  • Birmingham, Alabama
  • +50 more
Aug 10, 2022

NSCLC Trial in Worldwide (Alectinib, Docetaxel, Pemetrexed)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Alectinib
  • +2 more
  • Charleroi, Belgium
  • +53 more
Oct 7, 2019

Solid Tumors Trial in Worldwide (Entrectinib, Alectinib, Atezolizumab)

Recruiting
  • Solid Tumors
  • Daphne, Alabama
  • +156 more
Jan 13, 2023

Cancer of Unknown Primary Site Trial in Worldwide (Alectinib, Vismodegib, Ipatasertib)

Active, not recruiting
  • Cancer of Unknown Primary Site
  • Alectinib
  • +17 more
  • Blacktown, New South Wales, Australia
  • +140 more
Jan 6, 2023

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Hepatic Impairment Trial in Praha 7, Bratislava (Alectinib)

Completed
Has Results
  • Hepatic Impairment
  • Alectinib
  • Praha 7, Czechia
  • +1 more
Nov 7, 2017

NSCLC Trial in Canada, United States (Alectinib)

Completed
Has Results
  • Non-Small Cell Lung Cancer
  • Alectinib
  • Birmingham, Alabama
  • +41 more
Jul 23, 2018

Non-Small-Cell Lung Carcinoma Trial in Worldwide (Erlotinib, Alectinib)

Completed
Has Results
  • Non-Small-Cell Lung Carcinoma
  • Birmingham, Alabama
  • +83 more
Oct 31, 2018

NSCLC Trial in United States (Alectinib)

No longer available
  • Non-Small Cell Lung Cancer
  • Alectinib
  • Bimingham, Alabama
  • +44 more
Mar 7, 2017

Healthy Volunteer Trial in Austin (Alectinib, Posaconazole)

Completed
Has Results
  • Healthy Volunteer
  • Austin, Texas
    (unnamed)
Aug 16, 2016

Healthy Volunteer Trial in Austin (Alectinib, Esomeprazole, High Fat and Calorie Meal)

Completed
Has Results
  • Healthy Volunteer
  • Alectinib
  • +3 more
  • Austin, Texas
    (unnamed)
Aug 16, 2016